OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 12
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 12
Showing 12 citing articles:
Natural and synthetic potential drug leads for rheumatoid arthritis probing innovative target: mitochondrial dysfunction and NLRP3 inflammasome activation
Urooj Iqbal, Abdul Malik, Lamyaa F. Ibrahim, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Urooj Iqbal, Abdul Malik, Lamyaa F. Ibrahim, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The protective role of cannabidiol in stress-induced liver injury: modulating oxidative stress and mitochondrial damage
C. F. Huang, Huichao Liang, Xiaohua Liang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
C. F. Huang, Huichao Liang, Xiaohua Liang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
A predictive machine learning model for cannabinoid effect based on image detection of reactive oxygen species in microglia
Patricia Sinclair, William Jeffries, Nadege Lebert, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320219-e0320219
Open Access
Patricia Sinclair, William Jeffries, Nadege Lebert, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320219-e0320219
Open Access
Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention
Yifan Jing, Ying Bai, Chao Liang, et al.
Cellular Signalling (2025), pp. 111780-111780
Closed Access
Yifan Jing, Ying Bai, Chao Liang, et al.
Cellular Signalling (2025), pp. 111780-111780
Closed Access
P2X7 receptors from the perspective of NLRP3 inflammasome pathway in depression: Potential role of cannabidiol
Elif Akçay, Hülya Karataş
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100853-100853
Open Access | Times Cited: 4
Elif Akçay, Hülya Karataş
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100853-100853
Open Access | Times Cited: 4
Protective Effects of Cannabidiol (CBD) against Qxidative Stress, but Not Excitotoxic-Related Neuronal Cell Damage—An In Vitro Study
Danuta Jantas, Monika Leśkiewicz, Magdalena Regulska, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 564-564
Open Access | Times Cited: 3
Danuta Jantas, Monika Leśkiewicz, Magdalena Regulska, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 564-564
Open Access | Times Cited: 3
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial
Dennis M. McNamara, Leslie T. Cooper, Yaron Arbel, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 3416-3424
Open Access | Times Cited: 3
Dennis M. McNamara, Leslie T. Cooper, Yaron Arbel, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 3416-3424
Open Access | Times Cited: 3
Focus on negatively regulated NLRs in inflammation and cancer
Jian Wang, Wenjing He, Chunhua Li, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112347-112347
Open Access | Times Cited: 2
Jian Wang, Wenjing He, Chunhua Li, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112347-112347
Open Access | Times Cited: 2
Cannabidiol suppresses silica-induced pulmonary inflammation and fibrosis through regulating NLRP3/TGF-β1/Smad2/3 pathway
Wei Shao, Jiazhen Zhang, Zongze Yao, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113088-113088
Closed Access | Times Cited: 1
Wei Shao, Jiazhen Zhang, Zongze Yao, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113088-113088
Closed Access | Times Cited: 1
Full‐spectrum cannabidiol reduces UVB damage through the inhibition of TGF ‐β1 and the NLRP3 inflammasome
Ismael Manuel Urrutia‐Ortega, Israel Valencia, Octavio Ispanixtlahuatl-Meráz, et al.
Photochemistry and Photobiology (2024)
Open Access
Ismael Manuel Urrutia‐Ortega, Israel Valencia, Octavio Ispanixtlahuatl-Meráz, et al.
Photochemistry and Photobiology (2024)
Open Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis
Libin Xu, Siyu Li, Jiaxin Qi, et al.
Phytomedicine (2024) Vol. 136, pp. 156253-156253
Closed Access
Libin Xu, Siyu Li, Jiaxin Qi, et al.
Phytomedicine (2024) Vol. 136, pp. 156253-156253
Closed Access
